Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies.

Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration.

Lancet Diabetes Endocrinol. 2018 May 8. pii: S2213-8587(18)30079-2. doi: 10.1016/S2213-8587(18)30079-2. [Epub ahead of print]

2.

Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: results from the Asia Pacific Cohort Studies Collaboration.

Peters SAE, Wang X, Lam TH, Kim HC, Ho S, Ninomiya T, Knuiman M, Vaartjes I, Bots ML, Woodward M; Asia Pacific Cohort Studies Collaboration.

BMJ Open. 2018 Mar 6;8(3):e019335. doi: 10.1136/bmjopen-2017-019335.

3.

Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.

Kantito S, Saokaew S, Yamwong S, Vathesatogkit P, Katekao W, Sritara P, Chaiyakunapruk N.

J Thromb Thrombolysis. 2018 Feb;45(2):281-290. doi: 10.1007/s11239-017-1588-8.

PMID:
29181693
4.

Inhaled nebulized sodium nitrite decreases pulmonary artery pressure in β-thalassemia patients with pulmonary hypertension.

Yingchoncharoen T, Rakyhao T, Chuncharunee S, Sritara P, Pienvichit P, Paiboonsukwong K, Sathavorasmith P, Sirirat K, Sriwantana T, Srihirun S, Sibmooh N.

Nitric Oxide. 2018 Jun 1;76:174-178. doi: 10.1016/j.niox.2017.09.010. Epub 2017 Sep 28.

PMID:
28964835
5.

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group.

N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14.

6.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

7.

Risk scores to predict decreased glomerular filtration rate at 10 years in an Asian general population.

Saranburut K, Vathesatogkit P, Thongmung N, Chittamma A, Vanavanan S, Tangstheanphan T, Sritara P, Kitiyakara C.

BMC Nephrol. 2017 Jul 17;18(1):240. doi: 10.1186/s12882-017-0653-z.

8.

Management of atherosclerosis risk factors for patients at high cardiovascular risk in real-world practice: a multicentre study.

Phrommintikul A, Krittayaphong R, Wongcharoen W, Yamwong S, Boonyaratavej S, Kunjara-Na-Ayudhya R, Tatsanavivat P, Sritara P; CORE-Thailand Investigators.

Singapore Med J. 2017 Sep;58(9):535-542. doi: 10.11622/smedj.2017044. Epub 2017 May 25.

9.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

10.

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.

Ridker PM, Tardif JC, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C; SPIRE Investigators.

N Engl J Med. 2017 Apr 20;376(16):1517-1526. doi: 10.1056/NEJMoa1614062. Epub 2017 Mar 17.

11.

Prevalence of Brugada ECG Pattern in Thailand From a Population-Based Cohort Study.

Rattanawong P, Ngarmukos T, Chung EH, Vutthikraivit W, Putthapiban P, Sukhumthammarat W, Vathesatogkit P, Sritara P.

J Am Coll Cardiol. 2017 Mar 14;69(10):1355-1356. doi: 10.1016/j.jacc.2016.12.028. No abstract available.

12.

Cardio-Ankle Vascular Index in a Thai Population.

Yingchoncharoen T, Sritara P.

Pulse (Basel). 2017 Jan;4(Suppl 1):8-10. doi: 10.1159/000448490. Epub 2016 Dec 23. Review.

13.

Evaluation of the Framingham Heart Study risk factors and risk score for incident chronic kidney disease at 10 years in a Thai general population.

Saranburut K, Vathesatogkit P, Chittamma A, Vanavanan S, Thongmung N, Tangstheanphan T, Sritara P, Kitiyakara C.

Int Urol Nephrol. 2017 May;49(5):851-857. doi: 10.1007/s11255-017-1530-1. Epub 2017 Feb 9.

PMID:
28185105
14.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

15.

Age-Adjusted Dual X-ray Absorptiometry-Derived Trabecular Bone Score Curve for the Lumbar Spine in Thai Females and Males.

Sritara C, Thakkinstian A, Ongphiphadhanakul B, Amnuaywattakorn S, Utamakul C, Akrawichien T, Vathesatogkit P, Sritara P.

J Clin Densitom. 2016 Oct;19(4):494-501. doi: 10.1016/j.jocd.2015.05.068. Epub 2015 Jun 19.

16.

Hypertension and elevated heart rate: focus on the Asia Pacific region.

Tomlinson B, Sritara P, Lopez E, Dalal J, Erwinanto E, Pancholia AK.

J Hypertens. 2016 Dec;34(12):2330-2332. No abstract available.

PMID:
27805912
17.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators.

N Engl J Med. 2016 Nov 10;375(19):1834-1844. Epub 2016 Sep 15.

18.

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.

Wallentin L, Held C, Armstrong PW, Cannon CP, Davies RY, Granger CB, Hagström E, Harrington RA, Hochman JS, Koenig W, Krug-Gourley S, Mohler ER 3rd, Siegbahn A, Tarka E, Steg PG, Stewart RA, Weiss R, Östlund O, White HD; STABILITY Investigators.

J Am Heart Assoc. 2016 Jun 21;5(6). pii: e003407. doi: 10.1161/JAHA.116.003407.

19.

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.

McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators.

N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859. Epub 2016 Apr 4.

20.

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA; LATITUDE-TIMI 60 Investigators.

JAMA. 2016 Apr 19;315(15):1591-9. doi: 10.1001/jama.2016.3609.

PMID:
27043082

Supplemental Content

Loading ...
Support Center